Tirzepatide Weight Loss Capsules (Maintenance Phase)

Product Description

Is Tirzepatide an FDA-approved weight loss medication?

Not at this time. Tirzepatide is an FDA-approved injectable medication available by prescription for management of diabetes. Clinical trials and patient experience has shown it’s efficacy as a weight loss treatment.  Tirzepatide is being prescribed off-label by doctors for adults who are either overweight or obese.

Is Tirzepatide the same as Mounjaro™ for weight loss?

Yes. Mounjaro® is the brand name medication produced by Eli Lilly that contains Tirzepatide as the active ingredient. Tirzepatide should not be used while taking another GLP-1 receptor  such as Ozempic® or Wegovy™. Commonly known as Semaglutide.

How does Tirzepatide work?

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor . Tirzepatide mimics a hormone called glucagon-like peptide-1 (or GLP-1), which targets areas in the brain that regulate appetite and food intake.

How much weight can I lose with Tirzepatide?

Most patients lose up to 1-2 pounds per week on average with a weekly injection combined with a balanced diet and exercise.

What are the potential side effects of Tirzepatide?

The most common side effects of Tirzepatide are nausea and constipation.

You should avoid taking Tirzepatide if you or your family have a history of medullary thyroid carcinoma (MTC).

How is the Tirzepatide administered?

Tirzepatide is injected by the patient subcutaneously once per week on the same day of the week.